Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ZUGN.SW
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth n.A.
Leverage & Liquidity Balanced
50%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q4 Δ in %
Current Ratio 27.11 0.20 0.15
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 100.00 26.08 0.00
Naive Interpretation member
2 Per Share
Metric Q2 Q4 Δ in %
Book Value 100.00 1946.15 0.00
Cash 100.00 39.45 0.00
Capex -100.00 -6.87 0.00
Free Cash Flow 100.00 29.93 0.00
Revenue 100.00 82.14 0.00
Naive Interpretation member
3 Profitability
Metric Q2 Q4 Δ in %
Gross Margin 100.00 0.83 0.00
Operating Margin 100.00 0.55 0.00
ROA n.A. 0.01 n.A.
ROE n.A. 0.02 n.A.
ROIC n.A. 0.01 n.A.
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ZUGN.SW is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ZUGN.SW is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ZUGN.SW is permitted for members.